Genprex financials
$2.85+1.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$4.5M | -$4.5M | -$3.5M | -$3.3M | -$4.7M | -$4.0M | -$4.3M | -$4.3M | -$6.5M | -$6.0M | -$6.0M | -$7.8M |
| Net income | -$4.4M | -$4.5M | -$3.8M | -$3.8M | -$4.7M | -$4.0M | -$4.3M | -$4.3M | -$6.5M | -$6.2M | -$5.9M | -$7.7M |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-9.40 | $-14.08 | $-31.59 | $-110.00 | $-185.30 | $-285.56 | $-416.33 | $-1356.30 | $-3300.00 | $-4246.00 | $-4378.80 | $-5896.00 |
| EBITDA | -$4.5M | -$4.5M | -$3.5M | -$3.3M | -$4.7M | -$4.0M | -$4.3M | -$4.3M | -$6.5M | -$6.0M | -$6.0M | -$7.8M |
| Operating cash flow | -$5.1M | -$3.1M | -$4.1M | -$3.2M | -$3.9M | -$4.2M | -$3.9M | -$2.2M | -$6.6M | -$5.3M | -$5.0M | -$4.7M |
| Free cash flow | -$5.1M | -$3.1M | -$4.1M | -$3.2M | -$3.9M | -$4.2M | -$3.9M | -$2.2M | -$6.6M | -$5.3M | -$5.0M | -$4.7M |
| Diluted shares | 0.5M | 0.3M | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.2M | $18.0M | $7.8M | $1.1M | $1.3M | $3.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $17.1M | $20.3M | $10.2M | $3.6M | $3.8M | $6.0M |
| Total liabilities | $2.3M | $3.4M | $2.2M | $2.8M | $2.4M | $2.1M |
| Shareholders' equity | $14.8M | $16.9M | $8.0M | $767.8K | $1.4M | $3.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology